A carregar...
Bisphosphonates in the adjuvant treatment of young women with breast cancer: the estrogen rich is a poor candidate!
During the last 2 decades the role of bisphosphonates (BPs) to reduce skeletal-related events from bone metastases in breast cancer has been well defined. Several preclinical studies have strongly suggested that BPs may also provide an anti-cancer effect in early breast cancer. Indeed, the use of ad...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Pioneer Bioscience Publishing Company
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3695537/ https://ncbi.nlm.nih.gov/pubmed/23819025 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2072-1439.2013.06.04 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|